Pharmaceutical API Manufacturing Global Market Report 2024

Description

The manufacturing of pharmaceutical active pharmaceutical ingredients (API) involves producing the active substances that impart the desired impact on the body for the treatment of a specific condition in pharmaceutical medicines. To create APIs, chemical components undergo processing. The active component of a biological drug is termed a bulk process intermediate.

pharmaceutical API manufacturing focuses on various therapy areas, including cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutic uses. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels. Chemical API and biological API are the primary types used in the production of innovative drugs, generic prescription drugs, and over-the-counter (OTC) drugs.

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical active pharmaceutical ingredients (API) manufacturing market statistics, including pharmaceutical active pharmaceutical ingredients (API) manufacturing industry global market size, regional shares, competitors with a pharmaceutical active pharmaceutical ingredient (API) manufacturing market share, detailed pharmaceutical active pharmaceutical ingredients (API) manufacturing market segments, pharmaceutical active pharmaceutical ingredients (API) manufacturing market trends and opportunities, and any further data you may need to thrive in the pharmaceutical active pharmaceutical ingredients (API) manufacturing industry. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical API manufacturing market size has grown strongly in recent years. It will grow from $206.95 billion in 2023 to $219.76 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%.The growth in the historical period can be attributed to an increase in research and development (R&D) expenditure in the pharmaceutical sector, a growing preference for outsourcing active pharmaceutical ingredients (APIs), a rise in the prevalence of chronic illnesses, increased healthcare expenditure, a growth in disposable income, an increase in patent expiration, and the implementation of government policies promoting API production.

The pharmaceutical API manufacturing market size is expected to see strong growth in the next few years. It will grow to $279.03 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to the increasing aging population, rapid advancements in technology, a rising prevalence of cancer, increasing mergers and acquisitions, and the high potential of emerging economies, all of which will drive growth. Major trends in the forecast period include a focus on expanding production facilities, the use of artificial intelligence (AI), emphasis on greener API manufacturing, and increased investments and focus on the use of QR code labeling.

The increase in the aging population is a significant driver of the pharmaceutical API manufacturing market. With the rise in the aging population, there is a corresponding increase in the demand for pharmaceutical drugs. APIs play a crucial role in these medicines, serving as specialty drugs to address specific diseases. For example, an article shared by the World Health Organization (WHO) in October 2022 revealed that 80% of senior citizens are projected to reside in low- and middle-income nations by 2050. The aging population is growing at a faster rate than in the past, with more individuals over the age of 60 than under five-year-olds projected for 2020. Therefore, the growth of the aging population is a key factor driving the pharmaceutical API manufacturing market.

The surge in chronic conditions is anticipated to drive the pharmaceutical API manufacturing market in the future. Chronic conditions, or chronic diseases, are long-term health conditions that persist for extended periods, often throughout a person's lifetime, and typically cannot be completely cured. The quality, effectiveness, and safety of medications depend significantly on the API used. pharmaceutical API manufacturing plays a crucial role in producing essential medications for managing chronic diseases. For instance, according to the National Library of Medicine in 2023, it is projected that nearly 36% of US adults aged 50 and older will have at least one chronic condition by 2035, with this number expected to rise to almost 48% by 2050. Therefore, the increase in chronic conditions is a driving force for the pharmaceutical API manufacturing market.

Many companies leverage modern technologies such as process control and powder handling to optimize the manufacturing of Active Pharmaceutical Ingredients (API). These technologies include advancements in Lyophilization, a freeze-drying process involving low-temperature dehydration by freezing the product, lowering pressure, and removing the formed ice. For example, Telstar, a company specializing in efficient integrated systems for pharmaceutical and manufacturing processes, introduced LyoGistics Zero-an automatic loading and unloading system for freeze dryers designed for hazardous products. The system utilizes a linear magnetic driving mechanism, eliminating racks and belts to reduce particle generation and enhance hygiene in API manufacturing. Additionally, ILC Dover, a pharmaceutical company, developed the JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders to improve their mixing in a solution.

Key companies in the pharmaceutical API manufacturing market are dedicated to developing innovative solutions such as Apisolex to streamline manufacturing processes and minimize API loss. Apisolex, launched by Lubrizol Life Science (LLS) Health in March 2022, is a novel solubility-enhancing excipient technology addressing solubility challenges. It can significantly enhance solubility, support high drug loading, and optimize manufacturing efficiency by reducing API loss and ensuring efficient encapsulation.

In March 2021, Piramal Pharma Ltd., an India-based healthcare solutions company, acquired Hemmo Pharmaceuticals for $105.8 million. This strategic acquisition is poised to expand PPS's capacity to offer integrated services globally, providing access to the growing peptide API industry. The deal is expected to augment peptide API manufacturing and development capabilities. Hemmo Pharmaceuticals, based in India, specializes in the development and manufacturing of peptide APIs.

Major companies operating in the pharmaceutical API manufacturing market report are Pfizer Inc., Sanofi S.A, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories, BASF SE, Sun Pharmaceutical Industries Ltd., Novartis AG, Lupin Ltd., Cipla Inc., Arlak Biotech, Healthkind Labs Pvt. Ltd., SwisscheM Healthcare Pvt. Ltd., Apikos Pharma, Kolaz Biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc., Otsuka Pharmaceutical Co, Ltd., Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical, Sankyo, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Vectura Group, Roche Holding AG, Merck & Co, Boehringer Ingelheim, Zentiva, Microgen, Geropharm, Valenta, NovaMedica, Veropharm, Celon Pharma, SynBio, Generium, Skopinpharm, ALMEDIS, Biocad, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, Mylan, BioVectra, Celgene Corporation, Kashiv Pharma, Cambrex, Eli Lilly and Company, Bristol-Myers Squibb Company, Apotex, Gilead Sciences, AbbVie Inc., Hisun USA Inc., AMEGA Biotech, BioMarin Pharmaceutical, Ferring Pharmaceuticals, Tikun Olam Cannbit, Wavelength Pharmaceuticals, SAUDIBIO, Tabuk Pharmaceuticals, Bayer, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd., Aspen

North America was the largest region in the pharmaceutical API manufacturing market in 2023. The Middle East is expected to be the fastest-growing region in the global pharmaceutical API manufacturing market share during the forecast period. The regions covered in the pharmaceutical API manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical API manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The pharmaceutical active pharmaceutical ingredients (API) manufacturing market includes tablets, capsules, creams, and injectable sales. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical API Manufacturing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical api manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical api manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical api manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Therapy Area: Cardiovascular Disorders; Metabolic Disorders; Neurological Disorders; Oncology; Musculoskeletal Disorders; Other Therapeutics Uses
2) By API Type: Chemical API; Biological API
3) By Drug Type: Prescription Drugs; Over-The-Counter (OTC) Drugs
Companies Mentioned: Pfizer Inc; Sanofi S.A; Teva Pharmaceutical Industries Ltd.; Aurobindo Pharma; Dr. Reddy's Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r14570

1. Executive Summary

2. Pharmaceutical API Manufacturing Market Characteristics

3. Pharmaceutical API Manufacturing Market Trends And Strategies

4. Pharmaceutical API Manufacturing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pharmaceutical API Manufacturing Market Size and Growth

5.1. Global Pharmaceutical API Manufacturing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pharmaceutical API Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pharmaceutical API Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pharmaceutical API Manufacturing Market Segmentation

6.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cardiovascular disorders
Metabolic disorders
Neurological disorders
Oncology
Musculoskeletal disorders
NSAIDs
Other therapeutics uses
6.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemical API
Biological API
6.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription Drugs
Over-the-counter (OTC) Drugs

7. Pharmaceutical API Manufacturing Market Regional And Country Analysis

7.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pharmaceutical API Manufacturing Market

8.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pharmaceutical API Manufacturing Market

9.1. China Pharmaceutical API Manufacturing Market Overview
9.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pharmaceutical API Manufacturing Market

10.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pharmaceutical API Manufacturing Market

11.1. Japan Pharmaceutical API Manufacturing Market Overview
11.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pharmaceutical API Manufacturing Market

12.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pharmaceutical API Manufacturing Market

13.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pharmaceutical API Manufacturing Market

14.1. South Korea Pharmaceutical API Manufacturing Market Overview
14.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pharmaceutical API Manufacturing Market

15.1. Western Europe Pharmaceutical API Manufacturing Market Overview
15.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pharmaceutical API Manufacturing Market

16.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pharmaceutical API Manufacturing Market

17.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pharmaceutical API Manufacturing Market

18.1. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pharmaceutical API Manufacturing Market

19.1. Italy Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pharmaceutical API Manufacturing Market

20.1. Spain Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pharmaceutical API Manufacturing Market

21.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview
21.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pharmaceutical API Manufacturing Market

22.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pharmaceutical API Manufacturing Market

23.1. North America Pharmaceutical API Manufacturing Market Overview
23.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pharmaceutical API Manufacturing Market

24.1. USA Pharmaceutical API Manufacturing Market Overview
24.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pharmaceutical API Manufacturing Market

25.1. Canada Pharmaceutical API Manufacturing Market Overview
25.2. Canada Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pharmaceutical API Manufacturing Market

26.1. South America Pharmaceutical API Manufacturing Market Overview
26.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pharmaceutical API Manufacturing Market

27.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pharmaceutical API Manufacturing Market

28.1. Middle East Pharmaceutical API Manufacturing Market Overview
28.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pharmaceutical API Manufacturing Market

29.1. Africa Pharmaceutical API Manufacturing Market Overview
29.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

30.1. Pharmaceutical API Manufacturing Market Competitive Landscape
30.2. Pharmaceutical API Manufacturing Market Company Profiles
- 30.2.1. Pfizer Inc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi S.A
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Teva Pharmaceutical Industries Ltd.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Aurobindo Pharma
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Dr. Reddy's Laboratories
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pharmaceutical API Manufacturing Market Other Major And Innovative Companies

31.1. BASF SE
31.2. Sun Pharmaceutical Industries Ltd
31.3. Novartis AG
31.4. Lupin Ltd
31.5. Cipla Inc.
31.6. Arlak Biotech
31.7. Healthkind Labs Pvt. Ltd
31.8. SwisscheM Healthcare Pvt. Ltd
31.9. Apikos Pharma
31.10. Kolaz Biotech
31.11. CStone Pharma
31.12. CARsgen Therapeutics
31.13. JW Therapeutics
31.14. BeiGene
31.15. Takeda Pharmaceuticals

32. Global Pharmaceutical API Manufacturing Market Competitive Benchmarking

33. Global Pharmaceutical API Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

35. Pharmaceutical API Manufacturing Market Future Outlook and Potential Analysis

35.1 Pharmaceutical API Manufacturing Market In 2028 - Countries Offering Most New Opportunities
35.2 Pharmaceutical API Manufacturing Market In 2028 - Segments Offering Most New Opportunities
35.3 Pharmaceutical API Manufacturing Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer